Patient No | Paraesthesia | Pain | Sensory loss | DTR | Neurophysiological classification | Significant SNAPa changes | Antecedent infectious symptoms | Antiganglioside IgG | ||
GM1 | GD1a | GD1b | ||||||||
1 | − | − | − | − | AMAN/AD | − | Diarrhoea/fever | – | – | – |
2* | − | − | − | − | AMAN/AD | − | Diarrhoea | 51 200 | – | 800 |
3 | + | − | − | − | AMAN/AD | + | Diarrhoea/fever | ND | ND | ND |
4 | − | − | − | − | AMAN/AD | + | Diarrhoea | – | 12 800 | – |
5 | − | + | − | − | AMAN/AD | + | Flu | 1600 | 6400 | – |
6 | − | − | − | + | AMAN/AD | + | Diarrhoea/fever | – | 1600 | – |
7 | − | + | − | + | AMAN/AD | + | Diarrhoea/fever | 1600 | 51 200 | – |
8* | − | − | − | − | AMAN/AD | + | Diarrhoea | 3200 | 12 800 | – |
9 | − | + | − | ++ | AMAN/RCF | + | Diarrhoea | 51 200 | 102 400 | 102 400 |
10 | − | − | − | + | AMAN/RCF | − | Diarrhoea | 51 200 | 102 400 | – |
11 | + | − | − | + | AMAN/RCF | − | Diarrhoea/fever | – | – | 400 |
12 | − | − | − | − | AMAN/AD/MSA | + | Diarrhoea | – | – | – |
13 | − | + | − | − | AMAN/AD/MSA | + | Diarrhoea | 6400 | 1600 | 400 |
14 | + | − | + | − | AMSAN/AD | − | URTI | 400 | 400 | 800 |
15* | + | − | + | − | AMSAN/AD | + | Diarrhoea | 51 200 | – | 12 800 |
16* | + | + | + | − | AMSAN/RCF | + | Diarrhoea/fever | 400 | – | 400 |
The titre of IgG to gangliosides is reported. Paraesthesia and pain were reported to be present (+) or absent (−). DTR were absent/hypoactive (−), preserved (+) or brisk (++).
↵* Patients who were prospectively evaluated.
AD, axonal degeneration pattern in motor fibres; AMAN, acute motor axonal neuropathy; AMSAN, acute motor and sensory axonal neuropathy; DTR, deep tendon reflexes; MSA, minor sensory abnormalities at baseline; RCF, reversible conduction failure pattern in motor fibres; SNAPa, sensory nerve action potential amplitude; URTI, upper respiratory tract infection.